Identification and Characterisation of 5‐Hydroxytryptamine3 Recognition Sites in Human Brain Tissue

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Neurochemistry

• Publication date

  1989-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.1989.tb09244.xPMID 2809591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

  1989cited by this paper
• Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system

  1988cited by this paper
• Zacopride: anxiolytic profile in rodent and primate models of anxiety

  1988cited by this paper
• [3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.

  1988cited by this paper
• Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors

  1988cited by this paper
• Identification of 5‐HT3 recognition sites in human brain tissue using [3H]zacopride

  1988cited by this paper
• Identification of 5‐HT3 recognition sites in the ferret area postrema

  1988cited by this paper
• [3H]Zacopride: Ligand for the Identification of 5‐HT3 Recognition Sites

  1988cited by this paper
• Zacopride, a potent 5‐HT3 antagonist

  1988cited by this paper
• The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride

  1988cited by this paper
• [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.

  1988cited by this paper
• The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist

  1988cited by this paper
• Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes.

  1988cited by this paper
• The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.

  1988cited by this paper
• Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS.

  1988cited by this paper
• Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.

  1987cited by this paper
• Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.

  1987cited by this paper
• Antiemetic properties of the 5HT3-receptor antagonist, GR38032F.

  1987cited by this paper
• Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.

  1987cited by this paper
• Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist.

  1987cited by this paper
• Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

  1987cited by this paper
• Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

  1987cited by this paper
• First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis.

  1987cited by this paper
• Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret.

  1987cited by this paper
• Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility

  1986cited by this paper
• Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

  1986cited by this paper
• Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs

  1985cited by this paper
• Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

  1983cited by this paper
• Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

  1982cited by this paper
• Blockade of serotonin receptors on autonomic neurones by (-)-cocaine and some related compounds.

  1979cited by this paper
• Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.

  1978cited by this paper
• Blockade of neuronal tryptamine receptors by metoclopramide.

  1978cited by this paper
• Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Teratogenic efect of anticonvulsants.

  1973cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Decoding serotonin: the molecular symphony behind depression

  2025cites this paper
• 5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders

  2020cites this paper
• Stereological investigation of 5-HT3 receptors in the substantia nigra and dorsal raphe nucleus in the rat.

  2020cites this paper
• Bupropion inhibits serotonin type 3AB heteromeric channels at a physiologically relevant concentration

  2019cites this paper
• Yokukansan contains compounds that antagonize the 5-HT3 receptor.

  2018cites this paper
• Building a 5-HT3A Receptor Expression Map in the Mouse Brain

  2017cites this paper
• The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors

  2017cites this paper
• Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery

  2015cites this paper
• Genetics of serotonin receptors and depression: state of the art.

  2013cites this paper
• Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.

  2013cites this paper
• Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice.

  2012cites this paper
• Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: a European multicenter study

  2012cites this paper
• Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)

  2012cites this paper
• Tocris Bioscience Scientific Review Series Neuronal 5-ht Receptors and Sert Introduction

  2011cites this paper
• Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

  2011cites this paper
• Presynaptic control of serotonin on striatal dopamine function

  2011cites this paper
• Immunohistochemical characterization of 5-HT3A receptors in the Syrian hamster forebrain

  2010cites this paper
• Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood

  2010cites this paper
• Distribution of 5-HT Receptors in the Central Nervous System

  2010cites this paper
• 5-HT(3) receptors: role in disease and target of drugs.

  2010cites this paper
• Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression.

  2010cites this paper
• The 5-HT3 receptor--the relationship between structure and function.

  2009cites this paper
• Novel Analogs of m-Chlorophenylguanidine as 5-HT3 Receptor Ligands

  2009cites this paper
• 5-Hydroxytryptamine in the Central Nervous System

  2008cites this paper
• The role of 5-HT2 receptor subtypes in the control of micturition in urethane anaesthetized female rats.

  2008cites this paper
• Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization

  2008cites this paper
• 5-HT-3 Receptor

  2008cites this paper
• Identification of 5-HT3A and 5-HT3B receptor subunits in human hippocampus.

  2007cites this paper
• Risks and benefits of azathioprine therapy

  2005cites this paper
• Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

  2005cites this paper
• Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse

  2005cites this paper
• Differential Composition of 5-Hydroxytryptamine3Receptors Synthesized in the Rat CNS and Peripheral Nervous System

  2002cites this paper
• Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders.

  2002cites this paper
• Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT3 receptor.

  1999cites this paper
• 5-HT(3) receptor antagonists.

  1999cites this paper
• A review of central 5-HT receptors and their function.

  1999cites this paper
• Serotonergic modulation of neurotransmission in the rat basolateral amygdala.

  1999cites this paper
• Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017

  1998cites this paper
• Cognitive implications for H3 and 5-HT3 receptor modulation of cortical cholinergic function: a parallel story.

  1998cites this paper
• PROFILES OF THE AFFINITY OF ANTIPSYCHOTIC DRUGS FOR NEUROTRANSMITTER RECEPTORS AND THEIR CLINICAL IMPLICATION

  1998cites this paper
• Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.

  1998cites this paper
• Characterization of Desamino-5-[125I]Iodo-3-Methoxy-Zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain

  1998cites this paper
• The Central 5-HT3 Receptor in CNS Disorders

  1998cites this paper
• 5-HT3 receptors

  1997cites this paper
• The 5-HT3 Receptor Is Present in Different Subpopulations of GABAergic Neurons in the Rat Telencephalon

  1997cites this paper
• The protective effect of 5-HT3 receptor antagonist in thyrotropin releasing hormone-induced gastric lesions.

  1997cites this paper
• (S)-4-amino-5-chloro-3-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide (TRIZAC), a high-affinity ligand for the 5-HT-3 receptor

  1996cites this paper
• Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.

  1996cites this paper
• The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus.

  1996cites this paper
• Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy.

  1996cites this paper
• Therapeutic Potentials of Itasetron (DAU 6215), a Novel 5‐HT3 Receptor Antagonist, in the Treatment of Central Nervous System Disorders

  1996cites this paper
• Labeling of (S)‐DES‐4‐amino‐3‐[125I]iodozacopride (DAIZAC), a high‐affinity radioligand for the 5‐HT‐3 receptor

  1996cites this paper
• Characterization of a human 5‐hydroxytryptamine3 receptor type A (h5‐HT3R‐AS) subunit stably expressed in HEK 293 cells

  1996cites this paper
• 5‐Hydroxytryptamine (5‐HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases

  1995cites this paper
• Ondansetron improves cognitive performance in the Morris water maze spatial navigation task

  1995cites this paper
• Central control of breathing in mammals: neuronal circuitry, membrane properties, and neurotransmitters.

  1995cites this paper
• The interaction of RS 25259‐197, a potent and selective antagonist, with 5‐HT3 receptors, in vitro

  1995cites this paper
• Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats.

  1995cites this paper
• Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications.

  1995cites this paper
• The identification of heterogeneity of 5-HT3 receptors with [3H]RS-42358-197.

  1995cites this paper
• Therapeutic Potential of Serotonin 5-HT3 Antagonists in Neuropsychiatric Disorders

  1995cites this paper
• Motor-modifying properties of 5-HT3 and 5-HT4 receptor agonists on ovine abomasum.

  1994cites this paper
• Types of serotonergic receptors involved in the control of reticulo-ruminal myoelectric activity in sheep.

  1994cites this paper
• The role of 5-HT3 receptors in the anti-ulcer effect of calcitonin.

  1994cites this paper
• Poster communications.

  1993cites this paper
• Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala.

  1993cites this paper
• Labelling of 5‐Hydroxytryptamine3 Receptors with a Novel 5‐HT3 Receptor Ligand, [3H]RS‐42358–197

  1993cites this paper
• Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain

  1993cites this paper
• Different densities of 5-HT3 receptors are labeled by [3H]quipazine, [3H]GR 65630 and [3H]granisetron.

  1993cites this paper
• The 5-HT3 Receptor in Mammalian Brain: A New Target for the Development of Psychotropic Drugs?

  1993cites this paper
• Distribution and characterization of the [3H]granisetron-labelled 5-HT3 receptor in the human forebrain.

  1993cites this paper
• Positron emission tomographic studies of [11C]MDL 72222, a potential 5-HT3 receptor radioligand: distribution, kinetics and binding in the brain of the baboon.

  1993cites this paper
• Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington's disease.

  1993cites this paper
• Serotonin receptors and antipsychotic drug action.

  1993cites this paper
• Identification and distribution of 5‐HT3 recognition sites in the rat gastrointestinal tract

  1992cites this paper
• Membrane‐Bound and solubilized brain 5HT3 receptors: Improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H‐Gr65630C, 3H‐BRl43694, and 3H‐LY278584

  1992cites this paper
• Agonist interactions with 5‐HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands

  1992cites this paper
• Recent advances in pharmacological research on alcohol. Possible relations with cocaine.

  1992cites this paper
• Basic and Clinical Studies on Serotonin, Alcohol, and Alcoholism

  1992cites this paper
• Behavioural pharmacology of 5-HT3 receptor ligands.

  1992cites this paper
• Preclinical evidence for the anxiolytic activity of 5-HT3 receptor antagonists: A review

  1992cites this paper
• Inter-species variants of the 5-HT3 receptor.

  1992cites this paper
• Ondansetron and related 5-HT3 antagonists: recent advances.

  1992cites this paper
• Inhibition of [3H] γ‐aminobutyric acid release from guinea‐pig hippocampal synaptosomes by serotonergic agents

  1992cites this paper
• 5-Hydroxytryptamine receptors.

  1992cites this paper
• The 5-HT2 receptor in brain: recent biochemical and molecular biological developments and new perspectives in its regulation.

  1991cites this paper
• Ondansetron. Therapeutic use as an antiemetic.

  1991cites this paper
• The pharmacological characterization of 5-HT3 receptor binding sites in rabbit ileum: Comparison with those in rat ileum and rat brain

  1991cites this paper
• Effects of antipsychotic drugs on serotonin receptors.

  1991cites this paper
• Characterization of the 5‐HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5‐HT agonists in rats

  1991cites this paper
• Serotonergic Modulation of the Release of [ 3 H]GABA from Guinea-pig Hippocampal Synaptosomes

  1991cites this paper
• Granisetron

  1991cites this paper
• Molecular modeling of 5-HT3 receptor ligands.

  1991cites this paper
• Characteristics of 5‐HT3 binding sites in NG108‐15, NCB‐20 neuroblastoma cells and rat cerebral cortex using [3H]‐quipazine and [3H]‐GR65630 binding

  1991cites this paper
• The differential activities of R ( )- and S(-)-zacopride as 5-HT3 receptor antagonists.

  1990cites this paper
• Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem

  1990cites this paper
• Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.

  1990cites this paper
• Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers.

  1990cites this paper
• Presynaptic Receptors a Relevance to Psychotropic Drug Action in Man

  1990cites this paper
• Biochemical models for cognition enhancers.

  1990cites this paper